411 related articles for article (PubMed ID: 16211044)
1. New IGF drug stirs competition in growth factor segment.
Ratner M
Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
[No Abstract] [Full Text] [Related]
2. Biotech jostles with pharma for slice of HIV market.
Katsnelson A
Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
[No Abstract] [Full Text] [Related]
3. Deal watch: recent trends in deal-making.
Dawkes A; Papp T
Nat Rev Drug Discov; 2010 Dec; 9(12):909. PubMed ID: 21119724
[No Abstract] [Full Text] [Related]
4. Market watch: Biopharma deal-making in 2014: a record year for M&A value.
Micklus A; Muntner S
Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786
[No Abstract] [Full Text] [Related]
5. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
6. Bioentrepreneurship around the world.
Persidis A
Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
[No Abstract] [Full Text] [Related]
7. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
8. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
9. The biotech drug market.
Lawrence S
Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
[No Abstract] [Full Text] [Related]
10. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
11. HHS: POUFA reauthorization good for Americans.
FDA Consum; 2002; 36(5):5. PubMed ID: 12412536
[No Abstract] [Full Text] [Related]
12. Amgen's big-ticket play for Immunex.
Fletcher L
Nat Biotechnol; 2002 Feb; 20(2):105-6. PubMed ID: 11821840
[No Abstract] [Full Text] [Related]
13. Small molecule challenges dominance of TNF-alpha inhibitors.
Sheridan C
Nat Biotechnol; 2008 Feb; 26(2):143-4. PubMed ID: 18259158
[No Abstract] [Full Text] [Related]
14. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
15. Arguments against precompetitive collaboration.
Vargas G; Boutouyrie B; Ostrowitzki S; Santarelli L
Clin Pharmacol Ther; 2010 May; 87(5):527-9. PubMed ID: 20407456
[No Abstract] [Full Text] [Related]
16. Amgen asks judge for speedy ruling in patent case.
Nephrol News Issues; 1999 Dec; 13(12):14. PubMed ID: 11984928
[No Abstract] [Full Text] [Related]
17. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
18. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
19. Precompetitive research: a new prescription for drug development?
Woodcock J
Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
[No Abstract] [Full Text] [Related]
20. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
